Refine
Has Fulltext
- yes (208)
Is part of the Bibliography
- yes (208)
Year of publication
Document Type
- Journal article (106)
- Doctoral Thesis (100)
- Conference Proceeding (1)
- Review (1)
Language
- English (208) (remove)
Keywords
- HPLC (9)
- Bioverfügbarkeit (7)
- Instrumentelle Analytik (6)
- Löslichkeit (6)
- Muscarinrezeptor (6)
- NMR-Spektroskopie (6)
- Aminosäuren (5)
- Arzneimittel (5)
- Impurity Profiling (5)
- Ligand <Biochemie> (5)
- population pharmacokinetics (5)
- synthesis (5)
- Chemische Reinheit (4)
- Extrazelluläre Matrix (4)
- LC-MS/MS (4)
- Organische Synthese (4)
- Pharmakodynamik (4)
- Pharmakokinetik (4)
- Synthese (4)
- Synthesis (4)
- Targeted drug delivery (4)
- pharmacokinetics (4)
- therapeutic drug monitoring (4)
- Amino acids (3)
- Antibiotikum (3)
- Arzneimitteldesign (3)
- Biomarker (3)
- Charged Aerosol Detection (3)
- Formulierungsentwicklung (3)
- Interleukin 4 (3)
- Ionic Liquids (3)
- Kontrollierte Wirkstofffreisetzung (3)
- LC-MS (3)
- Metabolismus (3)
- Naturstoff (3)
- Pharmaceutical Analysis (3)
- Solubilisation (3)
- Tuberkelbakterium (3)
- Verunreinigung (3)
- Wirkstofffreisetzung (3)
- antibiotics (3)
- capillary electrophoresis (3)
- charged aerosol detector (3)
- chemistry (3)
- click chemistry (3)
- drug delivery (3)
- drug design (3)
- human (3)
- medicine (3)
- metabolism (3)
- muscarinic receptors (3)
- natural products (3)
- nutrition (3)
- polyphenols (3)
- positron emission tomography (3)
- protein binding (3)
- solubility (3)
- ARONJ (2)
- Agonist (2)
- Alzheimerkrankheit (2)
- Alzheimer’s disease (2)
- Analoga (2)
- Antimikrobieller Wirkstoff (2)
- Arzneimittelforschung (2)
- Arzneimittelüberwachung (2)
- Bitopische Liganden (2)
- Butyrylcholinesterase (2)
- Candida albicans (2)
- Chemie (2)
- Chemische Synthese (2)
- Cholinesterase (2)
- Chromatographie (2)
- Cytokine (2)
- Enterobacteriaceae (2)
- Ernährung (2)
- Fettsäurebiosynthese (2)
- Fibroblastenwachstumsfaktor (2)
- Flavonoids (2)
- Formulation development (2)
- Formulierung (2)
- GTP-bindende Proteine (2)
- Imatinib (2)
- Inhibitor (2)
- Insulin-like Growth Factor I (2)
- Kapillarelektrophorese (2)
- Lebensmittelchemie (2)
- Lipide (2)
- Massenspektrometrie (2)
- Medizin (2)
- NMR spectroscopy (2)
- Permeabilität (2)
- Pharmacokinetic (2)
- Pharmazeutischer Hilfsstoff (2)
- Polyethylenglykole (2)
- Polymere (2)
- Poorly water soluble drugs (2)
- Populationskinetik (2)
- Populationspharmakokinetik (2)
- Positronen-Emissions-Tomografie (2)
- Protease-sensitive release (2)
- Pycnogenol (2)
- Qualitätskontrolle (2)
- Reinheitsanalytik (2)
- S-ADAPT (2)
- Stabilität (2)
- Staphylococcus aureus (2)
- Struktur-Aktivitäts-Beziehung (2)
- Supersaturation (2)
- Tandem-Massenspektrometrie (2)
- Tissue Engineering (2)
- Trypanosomiase (2)
- Tryptophan (2)
- Valeriana wallichii (2)
- Wirkstoff (2)
- allometric scaling (2)
- antileishmanial (2)
- azobenzenes (2)
- baclofen (2)
- biomarker (2)
- body composition (2)
- body size (2)
- butyrylcholinesterase (2)
- chiral separation (2)
- clinical study (2)
- crystal structure (2)
- cystic fibrosis patients (2)
- cytochrome P450 3A4 (CYP3A4) (2)
- dendritic cells (2)
- drugs (2)
- drug–drug interactions (DDIs) (2)
- dualsteric ligands (2)
- endothelium (2)
- estrogens (2)
- extracellular matrix (2)
- fatty acid biosynthesis (2)
- gene expression (2)
- graft versus host disease (2)
- healthy volunteers (2)
- human breast (2)
- impurity profiling (2)
- in vitro (2)
- kinetics (2)
- leishmaniasis (2)
- liquid chromatography (2)
- marine sponge (2)
- mass spectrometry (2)
- molecular modeling (2)
- multiple linear regression (2)
- neuroprotection (2)
- norepinephrine transporter (2)
- octopamine (2)
- oral bioavailability (2)
- osteoarthritis (2)
- osteonecrosis of the jaw (2)
- osteoradionecrosis (2)
- permeability (2)
- pharmaceutical analysis (2)
- pharmacodynamics (2)
- physiologically based pharmacokinetic (PBPK) modeling (2)
- screening (2)
- staphylococcus aureus (2)
- strategy (2)
- structure-activity relationship (2)
- structure-activity relationships (2)
- sympathetic nervous system (2)
- therapy (2)
- thermogenesis (2)
- ultrafiltration (2)
- 1 (1)
- 17beta-Estradiol (1)
- 17beta-estradiol (1)
- 2,5-diketopiperazines (1)
- 2-Thiazaphospholidines (1)
- 2-a:6 (1)
- 2-chloro (1)
- 2-halo (1)
- 2-imino- (1)
- 3 (1)
- 5-a']diindol (1)
- 5-a']diindole (1)
- 5-b']diindol (1)
- 5-b']diindole (1)
- 5]diazocino[1 (1)
- 77-LH-28-1 (1)
- AAA+ ATPase p97 (1)
- AChE inhibitor (1)
- AD mouse modele (1)
- ADAMTS (1)
- AGP (1)
- AOM/DSS (1)
- Acetaminophen (1)
- Acetylcysteinderivate (1)
- Achillea Fragrantissima (1)
- Acrylamid (1)
- Acrylamide (1)
- Actinomycetes (1)
- Active pharmaceutical ingredients (1)
- Adhäsion (1)
- Aescin (1)
- African Trypanosomiasis (1)
- Akt (1)
- Akt/PKB (1)
- Albendazol (1)
- Aldehyde (1)
- Alkamiden (1)
- Alkamides (1)
- Alkylpyrazine (1)
- Allosteric Modulator (1)
- Allosterisch Modurator (1)
- Allosterischer Effektor (1)
- Alzheimer (1)
- Alzheimer's diseas (1)
- Alzheimer's disease (1)
- Alzheimer′s disease (1)
- Amino Acids (1)
- Aminosäure (1)
- Anacardic acid derivatives (1)
- Anacardsäurederivate (1)
- Analyse (1)
- Analytical Quality by Design (1)
- Analytik (1)
- Anthocyane (1)
- Antibiotic (1)
- Antibiotika (1)
- Antiinfektiva (1)
- Antikörper (1)
- Antitrypanosomal (1)
- Antitrypanosomen (1)
- Antitumor (1)
- Arthrose (1)
- Arzneimittelwechselwirkung (1)
- Arzneistoffanalytik (1)
- Asymmetrie (1)
- Autoradiographie (1)
- Aziridines (1)
- BRAF mutation (1)
- Baclofen (1)
- Bakterien (1)
- Benzimidazole (1)
- Beta-2-Rezeptor (1)
- Bile (1)
- Bioaccessibility (1)
- Bioanalytik (1)
- Bioavailability (1)
- Bioconjugate (1)
- Biodistribution (1)
- Biologische Aktivität (1)
- Biologischer Abbau (1)
- Bioreactor System (1)
- Biosensor (1)
- Biotransformation (1)
- Bisoprolol (1)
- Bitopic Ligands (1)
- Blockcopolymere (1)
- Blut-Hirn-Schranke (1)
- Brustdrüse (1)
- Burkholderia pseudomallei Mip (1)
- C-3-substituiert (1)
- C-3-substituted (1)
- CAD detection (1)
- CAR T cells (1)
- CAR T-Zellen (1)
- CFC replacements (1)
- CO‐releasing molecules (CORMs) (1)
- CYP2C9 (1)
- CYP3A4 (1)
- Cabozantinib (1)
- Candida auris (1)
- Cannabinoid Receptor (1)
- Capillary Electrophoresis (1)
- Carbamate (1)
- Carbocistein (1)
- Carboxylates (1)
- Cecropia telenitida (1)
- Cerulenin (1)
- Characterization (1)
- Charged Aerosol Detektion (1)
- Charged aerosol detection (1)
- Charged aerosol detector (CAD) (1)
- Chemical stability (1)
- Chemometric (1)
- Chemometrie (1)
- Chewing Gum (1)
- Chinolon <2-> (1)
- Chinolonamide (1)
- Chinolonderivate (1)
- Chiralität (1)
- Chlorfluorkohlenstoffe (1)
- Cholinesteraseinhibitor (1)
- Chondrogenesis (1)
- Chromatographischer Detektor (1)
- Chromone (1)
- Citrus (1)
- Click-Chemie (1)
- Codon (1)
- Commercial preparations (1)
- Computational chemistry (1)
- Computational drug-design (1)
- Contaminants (1)
- Controlled release (1)
- Corona charged aerosol detector (1)
- Counterfeit Medicines (1)
- Cutaneous leishmaniasis (1)
- Cyclo-AMP (1)
- Cyclo-GMP (1)
- Cytochrom P-450 (1)
- Cytotoxicity (1)
- Cytotoxizität (1)
- DNA-encoded library synthesis (1)
- DNA-tagged amines (1)
- DPP IV (1)
- Deep Eutectics (1)
- Derivsatisierung (1)
- Detektor (1)
- Diabetes mellitus (1)
- Diagnostik (1)
- Dickdarmkrebs (1)
- Dimere (1)
- Dimerisierung (1)
- Dosis (1)
- Dosislinearität (1)
- Drug delivery platform (1)
- Drug delivery platforms (1)
- Drug design (1)
- Drug form selection (1)
- EDC-NHS chemistry (1)
- EDTA (1)
- East Africa (1)
- Effluxpumpen (1)
- Electrospinning (1)
- Elektronensprayionisations-Massenspektrometrie (1)
- Enantiomere (1)
- Enantiomerentrennung (1)
- Enantiomerüberschuss (1)
- Enantioselektivität (1)
- Encapsulation (1)
- Endothel (1)
- Enoyl-Reduktase (1)
- Enoyl-acyl-carrier-protein-Reductase (1)
- Enoyl-acyl-carrier-protein-Reductase <Enoyl-[acyl-carrier-protein]-Reductase> (1)
- Enzym (1)
- Enzyme inhibitor (1)
- Enzyminhibitor (1)
- Ephedrin (1)
- Eriodictyon californicum (1)
- Ersatzstoff (1)
- Escherichia coli (1)
- Estradiol (1)
- Estrogens (1)
- Europäsches Arzneibuch (1)
- Excipient selection (1)
- Expiry date (1)
- Extrakt (1)
- FCKW-Ersatzstoffe (1)
- FGF (1)
- FGF-2 (1)
- FRET (1)
- FV45 (1)
- FabI (1)
- Fatty acids (1)
- Fertigarzneimittel (1)
- Fett (1)
- Fettgewebe (1)
- Fettkennzahlen (1)
- Fettsäurestoffwechsel (1)
- Flavoniden (1)
- Flavonoide (1)
- Flavonoinds (1)
- Fluoreszenz (1)
- Fluoreszenz-Resonanz-Energie-Transfer (1)
- Fluoreszenzliganden (1)
- Fluoreszenzmikroskopie (1)
- Fluoreszenzpolarisation (1)
- Fluorine (1)
- Fluorverbindungen (1)
- Flux (1)
- Flüssigkeitschromatographie (1)
- Formulation (1)
- Functional properties (1)
- Funktionalisierung <Chemie> (1)
- Funktionalisierung von elektrogesponnenen Fasern (1)
- Fälschung (1)
- G-Protein gekoppelte Rezeptor (1)
- G-protein coupled receptor (1)
- GABA (1)
- GABA-Rezeptor-Agonist (1)
- GABAB (1)
- GABAB receptor agonists (1)
- GABA\(_{A}\) receptor (1)
- GABA\(_{B}\) (1)
- GPCR (1)
- Galle (1)
- Galle <Sekret> (1)
- Gallensalze (1)
- Gas chromatography (1)
- Gaschromatographie (1)
- Gentamicin (1)
- Geschichte (1)
- Glutamate (1)
- Glycinrezeptor (1)
- Glycoengineering (1)
- Glykosylierung (1)
- Gradient boosted trees (GBT) (1)
- Gyrasehemmer (1)
- HIV (1)
- HNSCC (1)
- HPLC-MS (1)
- HPLC–MS (1)
- Hepatotoxizität (1)
- High-performance liquid chromatography (1)
- High-performance liquid chromatography (HPLC) (1)
- Humane Afrikanische Trypanosomiasis (1)
- Hybrid (1)
- Hybrid GPCR Ligands (1)
- Hybrid-Molecules (1)
- Hybridliganden (1)
- Hydrogen-deuterium (1)
- Hydroperoxide (1)
- Hypoxia (1)
- Hypoxie (1)
- Hülsenfrüchte (1)
- IGF-I (1)
- IR (1)
- ISPMF (1)
- Ibuprofen (1)
- Imidates (1)
- Imidoyl halides (1)
- Impact-Faktor (1)
- In vitro (1)
- In vivo (1)
- In vivo studies (1)
- InhA (1)
- Inhalation (1)
- Inhibition (1)
- Insulin-like Growth Factor (1)
- Insulin-like growth factor-I (1)
- Integrasen (1)
- Interferon <alpha-2a-> (1)
- Ion Pairs (1)
- Ionic Liquid (1)
- Ionische Flüssigkeit (1)
- Isocyanate (1)
- Isolation and Characterization (1)
- Isotopenverhältnis-Massenspektrometrie (1)
- JAK inhibitor (1)
- Karibisches Meer (1)
- KasA (1)
- Kaugummi (1)
- Ketamin (1)
- Ketoacyl-ACP-Synthase <beta-> (1)
- Ketoacyl-ACP-synthase (1)
- Kiefernrindenextrakt (1)
- Kinaseinhibitor (1)
- Klebsiella pneumoniae (1)
- Klinische Studie (1)
- Knochenpenetration (1)
- Knorpelbildung (1)
- Kohlenhydrate (1)
- Kohlenmonoxid (1)
- Kokristallisation (1)
- Konjugation (1)
- Kristall (1)
- Kristallstruktur (1)
- LC-ESI/MS/MS (1)
- LMICS (1)
- Lactamantibiotikum <beta-> (1)
- Lebensmittelprodukte (1)
- Leber (1)
- Lebertoxizität (1)
- Legionella pneumophila (1)
- Legionnaires' Disease (1)
- Legionärskrankheit (1)
- Leishmania (1)
- Leishmaniose (1)
- Library of Phytochemicals (1)
- Library of plant species (1)
- Lipid-Peroxide (1)
- Liposomen (1)
- Low-income Countries (1)
- LpxC inhibitors (1)
- Lungenentzündung (1)
- Lungenkrebs (1)
- Lungenperfusionsmodell (1)
- M1 Muscarinic Receptor (1)
- M2 (1)
- M4 (1)
- MDR (1)
- MIR-Spektroskopie (1)
- MRONJ (1)
- MRSA (1)
- MYCNv (1)
- Makrophage (1)
- Malaria (1)
- Manganese Carbonyl ligands (1)
- Markierte Verbindungen (1)
- Masspectrometry (1)
- Matrix Effekte (1)
- Maus (1)
- Mebendazol (1)
- Melatonin (1)
- Merkaptursäuren (1)
- Metabolism (1)
- Method Validation (1)
- Microglia (1)
- Microwave Assisted Extraction (1)
- Mikrosphären (1)
- Milchdrüse (1)
- Mip (1)
- Mip Inhibitoren (1)
- Mip inhibitor (1)
- Mitsunobu (1)
- Modellierung (1)
- Modifikation von Biokeramiken (1)
- Molecular modelling (1)
- Molekular Modeling (1)
- Molekulardesign (1)
- Molekulardynamik (1)
- Monoklonaler Antikörper (1)
- Monomere (1)
- Monte Carlo Simulation (1)
- Monte Carlo simulation (1)
- Mucus (1)
- Mukovisdizose (1)
- Mukoviszidose (1)
- Multidrugresistant (1)
- Muscarinic receptor (1)
- Muskarinrezeptor (1)
- Muskelatrophie (1)
- Myositis (1)
- NIR-Spektroskopie (1)
- NMR Spektroskopie (1)
- NOX-Inhibitoren (1)
- Naproxen (1)
- Natural product hybrids (1)
- Nature-Insipired Synthesis (1)
- Neuroprotection (1)
- Neuroprotektion (1)
- ONJ (1)
- Oberflächenfunktionalisierung (1)
- Opiatrezeptor (1)
- Osmunda regalis (1)
- Osteoarthritis (1)
- PDGF (1)
- PDGFR (1)
- PET (1)
- PI3K/Akt/mTor pathway (1)
- PPIase (1)
- Paeonia (1)
- Paracetamol (1)
- Paraffin (1)
- Parameter Quality Oil (1)
- Parenteral (1)
- Peptidsynthese (1)
- Peroxidzahl (1)
- Pflanzen (1)
- Pharmacokinetics (1)
- Pharmakologie (1)
- Pharmakometrie (1)
- Pharmakotherapie (1)
- Pharmazie (1)
- Phase separation (1)
- Phenolic acids (1)
- Pilocarpin (1)
- Pilokarpin (1)
- Plant extracts (1)
- Plants (1)
- Platelet-derived Growth Factor (1)
- Point-of-Care-testing (1)
- Polyglycerol (1)
- Polymilchsäure (1)
- Polyphenole (1)
- Poorly water-soluble drug (1)
- Praziquantel (1)
- Probenaufarbeitung (1)
- Proliferation (1)
- Propenderivate (1)
- Proteasen (1)
- Protein Expression (1)
- Protein crystal (1)
- Protein-Protein-Wechselwirkung (1)
- Proteinbindung (1)
- Proteine (1)
- Protic Ionic Liquids (1)
- Protonen-NMR-Spektroskopie (1)
- Präamplifizierung (1)
- Pulmonale Applikation (1)
- Pulmonary delivery (1)
- Purity control (1)
- Pyridin (1)
- Pyrimidinone (1)
- Pyroglutaminsäure (1)
- Quality ccontrol (1)
- Quantitative 1H NMR (1)
- Quantitative structure-property relationship modeling (QSPR) (1)
- Quinolone Amides (1)
- Quinolone amides (1)
- RESP model (1)
- Radioindikator (1)
- Radiopharmaka (1)
- Reaktive Zwischenstufe (1)
- Receptor Dynamics (1)
- Red Fruit Oil (1)
- Red Sea (1)
- Release system (1)
- Reproducibility challenges (1)
- Rhizom (1)
- Rifampicin (1)
- Risikobewertung (1)
- Risk Assessment (1)
- Robuvit\(^®\) (1)
- Ruxolitinib (1)
- Röstkaffee (1)
- SPECT (1)
- Salz (1)
- Schafgarbe <Gattung> (1)
- Schistosomiasis (1)
- Schleim (1)
- Schnelltest (1)
- Schwämme (1)
- Seide (1)
- Seiden-Fibroin (1)
- Sekundärmetabolit (1)
- Sensor (1)
- Sensoren (1)
- Sensors (1)
- Sesquiterpene lactones (1)
- Sesquiterpenlactonen (1)
- Shelf-life (1)
- Signaltransduktion (1)
- Silibinin (1)
- Silibinin ester (1)
- Silk Fibroin (1)
- Silk-Fibroin (1)
- Site-specific protein conjugation (1)
- Solubility (1)
- Sorafenib (1)
- Species Differences (1)
- Spectrofluorimetry (1)
- Speziesunterschiede (1)
- Spray drying (1)
- Springs and Parachutes (1)
- Sprühtrocknung (1)
- Stability (1)
- Stabilitätsstudien (1)
- Statine (1)
- Stereoselektive Synthese (1)
- Sternpolymere (1)
- Stoffwechsel (1)
- Streptomyces axinellae (1)
- Streptomycin (1)
- Strychnin (1)
- Strychnosalkaloide (1)
- Synthetische Biologie (1)
- Sythese (1)
- T cell (1)
- T-shaped π-π stacking (1)
- T-shaped π–π stacking (1)
- TDDFT (1)
- TDM (1)
- TGF-β3 (1)
- Tandem Mass Spectrometry (1)
- Tanzania (1)
- Tetrahydro-15aH-azocino[1 (1)
- Tetrahydro[1 (1)
- Tetrahydrochinazoline (1)
- Therapeutisches Drug Monitoring (1)
- Tierversuche (1)
- Tongue (1)
- Toxicokinetics (1)
- Toxikokinetik (1)
- Transgene Tiere (1)
- Trennung (1)
- Trypanosomen (1)
- Tuberculosis (1)
- Tuberkulose (1)
- Ugi-azide reaction (1)
- Universität Würzburg. Lehrstuhl für Pharmazeutische Technologie und Biopharmazie (1)
- Unterernährung (1)
- V. wallichii (1)
- Validierung (1)
- Vascularisation (1)
- Verderb (1)
- Verkapselung (1)
- Weakly chromophore impurities (1)
- West Africa (1)
- Wissenschaftliches Arbeiten (1)
- Wurmmittel (1)
- Xanomeline (1)
- Zelloberfläche (1)
- Zellwand (1)
- Zunge (1)
- Zytotoxizität (1)
- \(^{1}\)HNMR (1)
- absolute bioavailability (1)
- absorption (1)
- acebutolol (1)
- acetic acid (1)
- acetones (1)
- acetonitrile (1)
- acetylcholinesterase (1)
- acid value (1)
- acids (1)
- activation (1)
- additive manufacturing (1)
- adipose tissue (1)
- adipose tissue engineering (1)
- advanced drug delivery system (1)
- afatinib (1)
- affinity (1)
- agar diffusion test (1)
- albumin (1)
- aldehydes (1)
- alignment (1)
- alkylpyrazines (1)
- allergic rhinitis (1)
- allosteric modulation (1)
- amber codon suppression (1)
- amber light (1)
- amino acid (1)
- amorphous solid dispersion (1)
- ampicillin (1)
- amyloid beta (1)
- amyloid-β (Aβ) (1)
- angiotensin II type 1 receptor (1)
- animal studies (1)
- anisotropy (1)
- anti-infectives (1)
- anti-inflammatory activity (1)
- anti-inflammatory cytokines (1)
- anti-proliferative effects (1)
- anti-protease (1)
- anti-schistosomal activity (1)
- anti-trypanosomal (1)
- antibacterial activity (1)
- antibacterials (1)
- antibiotic (1)
- antibiotic bone concentration (1)
- antifungal drug (1)
- antimicrobial resistance (1)
- antimicrobial stewardship (1)
- antiresorptive drug-related osteonecrosis of the jaw (1)
- antiviral agents (1)
- at-home sampling (1)
- autoinjector (1)
- autophagy (1)
- baclofen homologues (1)
- beta-lactam (1)
- beta-lactam antibiotics (1)
- bile (1)
- bile salt (1)
- binding analysis (1)
- bio-orthogonal chemistry (1)
- bioactivity (1)
- bioavailability (1)
- bioceramics (1)
- biochemical simulations (1)
- biocide polyhexamethylene biguanide (1)
- bioconjugation (1)
- biodegradable polymer (1)
- biodiversity (1)
- bioisosterism (1)
- biologics (1)
- biologische Körperflüssigkeiten (1)
- biomaterials (1)
- biophysics (1)
- bioresponsive (1)
- biosensor (1)
- biosynthesis (1)
- bitopic hybrid ligands (1)
- bitopic ligand (1)
- bitopic ligands (1)
- blood brain barrier (1)
- blood plasma (1)
- boat conformation (1)
- bone marrow (1)
- bone penetration (1)
- bronchial tissue (1)
- brucei (1)
- cAMP (1)
- cGMP (1)
- caffeic acid bornyl ester (1)
- carbamate (1)
- cardiac innervation imaging (1)
- cardiac neurohormonal system (1)
- cartilage (1)
- cartilage tissue engineering (1)
- cecropia telenitida (1)
- cefotiam (1)
- cell metabolism (1)
- cells (1)
- cerebEND cells (1)
- cerulenin (1)
- chemical crosslinking (1)
- chemically programmable (1)
- chemisch programmierbar (1)
- chemotherapy (1)
- chenopodium quinoa (1)
- chiral (1)
- chiral resolution (1)
- chirale Trennung (1)
- cholesterol and oxy-cholesterol (1)
- cholinergic system (1)
- cholinesterase (1)
- cholinesterase inhibitors (1)
- cholinesterases inhibitors (1)
- chronic IBD model (1)
- circular dichroism (1)
- citrus (1)
- clinical pharmacy (1)
- co-delivery (1)
- cocrystal (1)
- cofactors (biochemistry) (1)
- cold stress (1)
- colloid (1)
- commercial preparations (1)
- complementary medicine (1)
- computational chemistry (1)
- contaminants (1)
- coupled (1)
- crithidia fasciulata (1)
- cyclodextrins (1)
- cysteine protease (1)
- cystic fibrosis (1)
- cytokine modulation (1)
- cytokine production (1)
- cytotoxicity (1)
- dabrafenib (1)
- decafluoroazobezene (1)
- dehydration (1)
- derivates (1)
- design of experiments (1)
- detector (1)
- diabetes (1)
- diketopiperazines (1)
- dimeric strychnine ligands (1)
- discovery (1)
- dissolution (1)
- dissolution rates (1)
- dose individualization (1)
- dose linearity (1)
- drug formulation (1)
- drug impurities (1)
- drug metabolism (1)
- drug monitoring (1)
- drug-delivery systems (1)
- dualsteric (1)
- dualsteric ligand (1)
- effector Treg (eTreg) (1)
- efflux pumps (1)
- electroactive (1)
- electrohydrodynamic (1)
- electrophoresis (1)
- electrospun fibers (1)
- emulsions oil-in-water (1)
- enantiomerenrein (1)
- enantiomers (1)
- enantiopure (1)
- enantioselectivity (1)
- enoyl reductase (1)
- enoyl-ACP reductase inhibitors (1)
- enterohepatic recirculation (1)
- enzyme kinetics (1)
- enzymes (1)
- ephedrine (1)
- epitope mapping (1)
- ester value (1)
- ethanol (1)
- ethers (1)
- eugenyl cinnamate (1)
- evaporation based detectors (1)
- evaporationsbasierte Detektoren (1)
- ex vivo Modell (1)
- exchange reaction (1)
- excipient (1)
- experimental visceral leishmaniasis (1)
- extra cellular matrix (1)
- extraction (1)
- fatty acids (1)
- fenoterol (1)
- field testing (1)
- flavonoid (1)
- flavonoids (1)
- fluorescence (1)
- fluorescence polarization (1)
- fluorescence resonance energy transfer (1)
- fluorescent ligands (1)
- fluorescent probes (1)
- fluorine-18 (1)
- fluoroquinolone (1)
- fluticasone propionate (1)
- flux (1)
- food (1)
- forms (1)
- formulation development (1)
- fragment screening (1)
- fragment-based design (1)
- free fatty acids (1)
- funktionale Präpolymere (1)
- gallotannins (1)
- gastrointestinal (1)
- genetic codon expansion (1)
- genetics (1)
- gentamicin sulfate (1)
- glucos metabolism (1)
- glucose (1)
- glutamates (1)
- glutathione (1)
- glycocalyx (1)
- glycolytic flux control (1)
- gprotein (1)
- gradient HPLC–UV (1)
- gut microbiota; bioactivation; polyphenols; complex carbohydrates; tryptophan (1)
- hMSC-TERT (1)
- halo olefines (1)
- head and neck carcinoma (1)
- heart failure (1)
- hepatotoxicity (1)
- high performance liquid chromatography (1)
- high throughput screening (1)
- high-resolution tandem mass spectrometry (1)
- high-throughput screening (1)
- histamine (1)
- history (1)
- homodimerization (1)
- homology modeling (1)
- honeybee (1)
- honeybees (1)
- human African trypanosomiasis (1)
- human nutrition (1)
- human plasma (1)
- human receptor kinetics (1)
- hybrid ligands (1)
- hybrid molecules (1)
- hydnocarpin (1)
- hydrogels (1)
- hydrogen bonding (1)
- hydrogen bonding mycobacterium tuberculosis (1)
- hydrolysis (1)
- hydroperoxides (1)
- hydroxy-dabrafenib (1)
- hypoxia (1)
- hysterectomy (1)
- imaging (1)
- immunomodulatory (1)
- impurities (1)
- in vitro dissolution methods (1)
- in vitro dissolution testing (1)
- in vitro-in vivo correlation (1)
- in vitro/in vivo Korrelation (1)
- in vitro/in vivo correlation (1)
- in vivo dissolution (1)
- information technology (1)
- inhibitors (1)
- injectable protein formulation (1)
- interleukin-4 (1)
- internal transcribed spacer 2 (1)
- intestinal mucus (1)
- intestinal permeability (1)
- intramolecular Michael addition (1)
- intranasal corticosteroids (1)
- intrinsic metabolism (1)
- invasion (1)
- iodine value (1)
- ion-pair chromatography (1)
- ionic liquids (1)
- ipratropium bromide (1)
- isocyanide multicomponent reactions (1)
- isolation (1)
- isomerization (1)
- isosteviol sodium (1)
- isotope ratio mass spectrometry (1)
- isotopically labelled peptides (1)
- jaw bone (1)
- kappa-B activation (1)
- kasA (1)
- ketamine (1)
- kinase inhibitor (1)
- kinase inhibitors (1)
- lactams (1)
- lattice forces (1)
- leaves (1)
- linear discriminant analysis (1)
- lipid deterioration (1)
- lipid deterioration markers (1)
- liposomes (1)
- liquid chromatography electrospray ionization tandem mass spectrometry (1)
- liquid chromatography tandem mass spectrometry (LC-MS/MS (1)
- liquid chromatography-mass spectrometry (1)
- liver (1)
- liver impairment (1)
- lowering lattice forces (1)
- lung perfusion model (1)
- mRNA level (1)
- mRNA-Spiegel (1)
- maceration (1)
- macrophages (1)
- magnesium stearate (1)
- mammary gland (1)
- manufacturer (1)
- marine metagenomics (1)
- marine natural products (1)
- marine organisms (1)
- maritime pine bark extract (1)
- matrix metalloproteinase (1)
- matrix metalloproteinases (1)
- mechanistic drug-drug interactions (1)
- mechanistische Arzneistoffinteraktionen (1)
- mechanochemical degradation (1)
- medicine authentication tools (1)
- melanoma (1)
- melatonin (1)
- mercapturic acids (1)
- metabolic glycoengineering (1)
- metabolic network (1)
- metabolic network model (1)
- metabolisches Netzwerk (1)
- metastasis (1)
- micelles (1)
- microscopy (1)
- microspheres (1)
- mixed-mode chromatography (1)
- mobile apps (1)
- modelling (1)
- modified monosaccharides (1)
- molecular biopharmaceutics (1)
- molecular dynamics (1)
- molecular mechanics (1)
- molecular systematics (1)
- molekulares Modellieren (1)
- monoclonal antibodies (1)
- monoklonale Antikörper (1)
- mucin (1)
- multicomponent Ugi-type reaction (1)
- muscarinic (1)
- muscarinic M1 receptor (1)
- muscarinic acetylcholine receptor (1)
- muscarinic acetylcholine receptors (1)
- mycobacterium tuberculosis (1)
- natural product (1)
- natural product hybrids (1)
- nerve agent (1)
- neuroblastoma cell (1)
- neuroprotective (1)
- neuroprotectivity (1)
- nicotinic receptors (1)
- nitric oxide (1)
- non-chromophore analytes (1)
- non-racemic (1)
- nonhuman primates (1)
- novel nepetolactone derivative (1)
- nuclear cardiology (1)
- nuclear magnetic resonance spectroscopy (1)
- oak wood (1)
- oak wood extract (1)
- obtusifolia bertol (1)
- octopamine receptors (1)
- oleanane saponins (1)
- online monitoring system (1)
- opioid ligands (1)
- opioid receptors (1)
- oral anticancer drugs (1)
- oral drug absorption (1)
- oral microbiome (1)
- osimertinib (1)
- osteochondral implant (1)
- oxidative stress (1)
- oxime (1)
- oxygen (1)
- oxytosis/ferroptosis (1)
- paraffins (1)
- parasite (1)
- paromomycin (1)
- patch clamp recording (1)
- pefloxacin (1)
- pentacyclic triterpene (1)
- peptide sensors (1)
- peptide stapling (1)
- perfluoroarylation (1)
- peri-implant disease (1)
- personalized antimicrobial therapy (1)
- pharmacodynamic (1)
- pharmacokinetic (1)
- pharmacological evaluation (1)
- pharmacology (1)
- pharmacometrics (1)
- phosphoglycolate phosphatase (1)
- photocontrol (1)
- photopharmacology (1)
- phylogenetic analysis (1)
- phylogenetic tree (1)
- phylogeny (1)
- phytochemicals (1)
- phytochemistry (1)
- phytomedicine (1)
- phytoneering (1)
- pig (1)
- pine bark extract (1)
- piperacillin/tazobactam (1)
- plant extract (1)
- plants (1)
- plasma proteins (1)
- podophyllotoxin (1)
- poly(2-ethyl-2-oxazoline) (1)
- polyethylenglykole (1)
- polylactid (1)
- polymer drug interaction (1)
- polymer processing (1)
- polymers (1)
- polysorbate 80 (1)
- poor water-soluble drugs (1)
- poorly water soluble drugs (1)
- posaconazole (1)
- post-operative recovery (1)
- post-surgery recovery (1)
- postsurgical adhesion (1)
- pressurized microwave‐assisted extraction (1)
- principal component analysis (1)
- pro-inflammatory cytokines (1)
- profiles (1)
- proliferation (1)
- propionate (1)
- protease inhibition (1)
- protease inhibitors (1)
- protease-sensitive release (1)
- proteasome system (1)
- protein engineering (1)
- protein modification (1)
- protein nebulization (1)
- protein therapeutics (1)
- psidium guajava; (1)
- pulmonary absorption (1)
- purification (1)
- pyridine (1)
- pyridobenzodiazepine (1)
- pyroglutamic acid (1)
- qNMR (1)
- qPCR (1)
- quality evaluation (1)
- quantitative 1H NMR (1)
- quantum mechanics (1)
- radiotracer (1)
- radiotracer kinetics (1)
- radiotracers (1)
- randomized controlled study (1)
- rat study (1)
- reactive metabolites (1)
- reaktive Metabolite (1)
- receptors (1)
- red blood cells (1)
- red fruit oil (1)
- renal cell carcinoma (1)
- renin-angiotensin system (1)
- replica-exchange molecular dynamics (1)
- required hydrophilic–lipophilic balance (1)
- residence time (1)
- resistance (1)
- response surface (1)
- ribosomal RNA (1)
- roast coffee (1)
- ruxolitinib (1)
- sacha inchi oil (1)
- saponification Value (1)
- saturation transfer difference NMR (1)
- scar revision surgery (1)
- schistosmiasis (1)
- schistosoma (1)
- schistosomula (1)
- secondary structure (1)
- secretion (1)
- sensor (1)
- sensory chewing gums (1)
- serjanic acid (1)
- serum (1)
- short-range order (1)
- silk fibroin (1)
- silybin (1)
- simple (1)
- simulated intestinal fluid (1)
- single-molecule microscopy (1)
- sisomicin (1)
- site-specific protein modification (1)
- soil-transmitted helminthiases (1)
- solid dispersion (1)
- solid-state NMR spectroscopy (1)
- spectrofluorimetry (1)
- sphingomonads (1)
- spray (1)
- steered molecular dynamics (1)
- sterubin (1)
- streptomyces (1)
- structural elucidation (1)
- structure–activity relationships (1)
- strychnine (1)
- subcutaneous fat layer (1)
- substandard and falsified medicines (1)
- surface functionalization (1)
- synovial fluid (1)
- system (1)
- tacrine (1)
- tandem mass spectrometry (1)
- tetromycin (1)
- therapeutic gases (1)
- thermodynamics (1)
- thin-layer chromatography (1)
- thymyl cinnamate (1)
- tofacitinib (1)
- tongue (1)
- topical treatment (1)
- toxicity (1)
- track and trace (1)
- trametinib (1)
- transglutaminase (1)
- transport (1)
- treatment regimens (1)
- triacylglycerides (1)
- trypanosoma cruzi (1)
- tuberculosis (1)
- type 2 diabetes (1)
- underutilized legumes (1)
- unnatural amino acid (1)
- unsaturated fatty acids (1)
- urolithins (1)
- ursolic acid (1)
- vacuoles (1)
- validation (1)
- valsartan (1)
- valtrates (1)
- vascularized fat construct (1)
- veterinarians (1)
- veterinary medicine (1)
- volumetric absorptive micro-sampling (VAMS) (1)
- volumetric absorptive microsampling (1)
- Öl (1)
- β2 - Agonisten (1)
- β2 - agonist (1)
Institute
- Institut für Pharmazie und Lebensmittelchemie (208) (remove)
Sonstige beteiligte Institutionen
- Universität Belgrad, Serbien (2)
- ACC GmbH Analytical Clinical Concepts (1)
- Apotheke, Universitätsklinikum Würzburg (1)
- Bundesinstitut für Arzneimittel und Medizinprodukte (1)
- Friedrich-Schiller-Universität Jena (1)
- Helmholtz Institute for RNA-based Infection Biology (HIRI), Josef-Schneider-Straße 2/D15, DE-9708 Wuerzburg, Germany (1)
- Helmholtz Institute for RNA-based Infection Biology (HIRI), Josef-Schneider-Straße 2/D15, DE-97080 Wuerzburg, Germany (1)
- IBMP - Institut für Biomedizinische und Pharmazeutische Forschung in Nürnberg-Heroldsberg (1)
- Johns Hopkins School of Medicine (1)
- Krankenhaushygiene und Antimicrobial Stewardship, Universitätsklinikum Würzburg (1)
EU-Project number / Contract (GA) number
- 26230120009 (1)
- 296679 (1)
- 314911 (1)
- 701983 (1)
The binding of drugs to plasma proteins is an important process in the human body and has a significant influence on pharmacokinetic parameter. Human serum albumin (HSA) has the most important function as a transporter protein. The binding of ketamine to HSA has already been described in literature, but only of the racemate. The enantiomerically pure S-ketamine is used as injection solution for induction of anesthesia and has been approved by the Food and Drug Administration for the therapy of severe depression as a nasal spray in 2019. The question arises if there is enantioselective binding to HSA. Hence, the aim of this study was to investigate whether there is enantioselective binding of S-and R-ketamine to HSA or not. Ultrafiltration (UF) followed by chiral capillary electrophoretic analysis was used to determine the extent of protein binding. Bound fraction to HSA was 71.2 % and 64.9 % for enantiomerically pure R- and S-ketamine, respectively, and 66.5 % for the racemate. Detailed binding properties were studied by Saturation Transfer Difference (STD)-, waterLOGSY- and Carr-Purcell-Meiboom-Gill (CPMG)-NMR spectroscopy. With all three methods, the aromatic ring and the N-methyl group could be identified as the structural moieties most strongly involved in binding of ketamine to HSA. pK\(_{aff}\) values determined using UF and NMR indicate that ketamine is a weak affinity ligand to HSA and no significant differences in binding behavior were found between the individual enantiomers and the racemate.
In DNA-encoded library synthesis, amine-substituted building blocks are prevalent. We explored isocyanide multicomponent reactions to diversify DNA-tagged amines and reported the Ugi-azide reaction with high yields and a good substrate scope. In addition, the Ugi-aza-Wittig reaction and the Ugi-4-center-3-component reaction, which used bifunctional carboxylic acids to provide lactams, were explored. Five-, six-, and seven-membered lactams were synthesized from solid support-coupled DNA-tagged amines and bifunctional building blocks, providing access to structurally diverse scaffolds.
In this thesis, a new approach of a qNMR method has been investigated to demonstrate the reliability and importance of this method as an alternative solution for analyzing oil quality parameters, especially in RFO, which has particular characteristics (red color). This study also includes the chemometric evaluation of spectral data for authentication, visual grouping, and prediction of RFO quality based on the degree of unsaturation, FFA value, and unsaturated fatty acid content.
The analytical measurement procedure of NMR spectroscopy begins with optimization of the analytical acquisition parameters, including effect of solvent, effect of sample concentration, selection of appropriate internal standards, determination of T1, and method validation. Furthermore, the results of the method development were interpreted to RFO samples evaluation, which began with determining the assignment of signal spectra for the determination of AV, SV, EV, and IV simultaneously with: the hydrolysis approach and standard addition of palmitic acid.
Even though the international combat against Neglected Tropical Diseases such as schistosomiasis or soil-transmitted helminthiases depends on reliable therapeutics, anthelminthic pharmacovigilance has been neglected on many national African drug markets. Therefore, quality and composition of 88 different batches of Albendazole, Mebendazole and Praziquantel locally collected from randomly selected facilities in Western Burkina Faso, Southeast Côte d’Ivoire, Southwest Ghana and Northwest Tanzania were analysed.
Visual examination of both packaging and samples was performed according to the WHO ‘Be Aware’ tool. Products were then screened with the GPHF Minilab, consisting of tests of mass uniformity, disintegration times and thin-layer chromatography (TLC). Confirmatory tests were performed according to international pharmacopoeiae, applying assays for dissolution profiles and high-performance liquid chromatography (HPLC).
Despite minor irregularities, appearance of the products did not hint at falsified medicines. However, 19.6 % of the brands collected in Ghana and Tanzania were not officially licensed for sale. Mass uniformity was confirmed in 53 out of 58 brands of tablets. 41 out of 56 products passed disintegration times; 10 out of the 15 failing products did not disintegrate at all.
TLC results did not reveal any falsifications or pronounced dosing errors. HPLC findings confirmed the TLC results despite shifted specification limits: ten of the 83 tested batches contained less than 90 %, none more than 110 % label claim. However, no more than 46.3 % (31 / 67) of the tablet batches assayed passed the respective criteria for dissolution.
In the four study countries, no falsified anthelminthic medicine was encountered. The active pharmaceutical ingredient was not found to either exceed or distinctively fall below specification limits. Galenic characteristics as most critical criteria however, especially dissolution profiles, revealed substantial deficits.
Poor or variable oral bioavailability is of major concern regarding safety and efficacy for the treatment of patients with poorly water-soluble drugs (PWSDs). The problem statement of this work involves a pharmaceutical development perspective, the physicochemical basis of the absorption process and physiological / biopharmaceutical aspects. A methodology was developed aiming at closing the gap between drug liberation and dissolution on the one hand and the appearance of drug in the blood on the other. Considering what is out of control from a formulation development perspective, a clear differentiation between bioavailability and bioaccessibility was necessary. Focusing on the absorption process, bioaccessibility of a model compound, a poorly soluble but well permeable weak base, was characterized by means of flux across artificial biomimetic membranes. Such setups can be considered to reasonably mimic relevant oral absorption resistances in vitro in terms of diffusion through an unstirred water layer (UWL) and a lipidic barrier. Mechanistic understanding of the driving force for permeation was gained by differentiating drug species and subsequently linking them to the observed transfer rates using a bioaccessibility concept. The three key species that need to be differentiated are molecularly dissolved drug, drug associated in solution with other components (liquid reservoir) and undissolved drug (solid reservoir). An innovative approach to differentiate molecularly dissolved drug from the liquid reservoir using ultracentrifugation in combination with dynamic light scattering as control is presented. A guidance for rational formulation development of PWSDs is elaborated based on the employed model compound. It is structured into five guiding questions to help drug formulation scientists in selecting drug form, excipients and eventually the formulation principle. Overall, the relevance but also limitations of characterizing bioaccessibility were outlined with respect to practical application e.g. in early drug formulation development.
All presented studies aimed on the improvement of the quality analysis of already monographed drugs. Thereby different LC methods were applied and coupled to i.e., the UV/VIS detector, the CAD or a hyphenation of these detectors, respectively. The choice of the chromatographic system including the detector was largely dependent on the physicochemical properties of the respective analytes.
With the risk-assessment report on the API cetirizine we presented an exemplary tool, that can help to minimize the risk of the occurrence of unexpected impurities. An in- deep analysis of each step within synthesis pathway by means of reaction matrices of all compounds was performed. It is essential to understand the complete impurity profile of all reactants, solvents, and catalysts and to include them in the matrix. Finally, the API of this synthesis was checked if all impurities are identified by this tool. Of note, a shortcoming of such a targeted approach is that impurities can still occur, but they are not captured. This disadvantage can be partially compensated by non-targeted approaches if they are performed in parallel with the other studies that represent most of the impurities. However, this work also shows that even in a supposedly simple synthesis, potentially hundreds of by-products can be formed. For each of them, it must be decided individually whether their formation is probable or how their quantity can be minimized in order to obtain APIs, that are as pure as possible.
In the dapsone project it was aimed to replace the existing old Ph. Eur. TLC method with a modern RP-HPLC method. This was successful and since Ph. Eur. 10.6, the method developed in this work, became a valid monograph. Within the revision process of the monograph, the individual limits for impurities were tightened. However, this new method needs HPLC instrumentation, suitable to perform gradients. As this is not always available in all control laboratories, we also developed an alternative, more simple method using two different isocratic runs for the impurity analysis. The obtained batch results of both, the new pharmacopoeial method and the more simple one, were in a comparable order of magnitude. Furthermore, within the method development stage of the Ph. Eur. method, we could identify one unknown impurity of the impurity reference by high-resolution MS/MS analysis.
Also, in the baclofen project it was aimed to replace the existing Ph. Eur. method with the introduction of an additional impurity to be quantified. A corresponding method was developed and validated. However, due to the harmonization process of the pharmacopoeias, it is currently not used. In addition, we tried to find further, non- 116
SUMMARY
chromophoric impurities by means of the CAD. However, except for one counterion of an impurity, no further impurities were found. Also, the aforementioned new impurity could not be detected above the reporting threshold in the batches analyzed. As the only individually specified impurity A is also present at a low level, it can be concluded that the examined batches of baclofen are very pure.
The use of universal detectors, such as the CAD can be particularly interesting for compounds with no chromophore or those with only a weak chromophore. Therefore, we decided to take a closer look at the impurity profile of acarbose. Currently, acarbose and its impurities are being studied by low wavelength UV detection at 210 nm. Therefore, the question arose whether there are no other impurities in the API that do not show absorption at this wavelength. CAD, which offers consistent detection properties for all non-volatile compounds, is ideally suited for this purpose. However, it was not so easy to use the CAD together with the UV detector, for example, as a hyphenated detection technique, because the Ph. Eur. method uses phosphate buffers. However, this is non-volatile and therefore inappropriate for the CAD. Therefore, an attempt was made to replace the buffer with a volatile one. However, since this did not lead to satisfactory results and rather the self-degradation process of the stationary phase used could be observed by means of the CAD, it was decided to switch to alternative stationary phases. A column screening also revealed further difficulties with acarbose and its impurities: they show an epimerization reaction at the end of the sugar chain. However, since one wanted to have uniform peaks in the corresponding chromatograms, one had to accelerate this reaction significantly to obtain only one peak for each component. This was best achieved by using two stationary phases: PGC and Amide-HILIC. Impurity-profiling methods could be developed on each of the two phases. In addition, as expected, new impurities could be detected, albeit at a low level. Two of them could even be identified by spiking experiments as the sugar fragments maltose and maltotriose.
Taken together, it can be concluded, that this work has contributed significantly to the improvement of the quality analysis of monographed drugs. In addition to the presented general tool for the identification of potential impurities, one of the methods developed, had already been implemented to the Ph. Eur. In an effort to improve the CAD's universal detection capabilities, additional methods have also been developed. Further, new improved methods for the impurity profiling are ready to use.
Formation of the Aurora-A–MYCN complex increases levels of the oncogenic transcription factor MYCN in neuroblastoma cells by abrogating its degradation through the ubiquitin proteasome system. While some small-molecule inhibitors of Aurora-A were shown to destabilize MYCN, clinical trials have not been satisfactory to date. MYCN itself is considered to be `undruggable' due to its large intrinsically disordered regions. Targeting the Aurora-A–MYCN complex rather than Aurora-A or MYCN alone will open new possibilities for drug development and screening campaigns. To overcome the challenges that a ternary system composed of Aurora-A, MYCN and a small molecule entails, a covalently cross-linked construct of the Aurora-A–MYCN complex was designed, expressed and characterized, thus enabling screening and design campaigns to identify selective binders.
Amber Light Control of Peptide Secondary Structure by a Perfluoroaromatic Azobenzene Photoswitch
(2023)
The incorporation of photoswitches into the molecular structure of peptides and proteins enables their dynamic photocontrol in complex biological systems. Here, a perfluorinated azobenzene derivative triggered by amber light was site‐specifically conjugated to cysteines in a helical peptide by perfluoroarylation chemistry. In response to the photoisomerization (trans→cis) of the conjugated azobenzene with amber light, the secondary structure of the peptide was modulated from a disorganized into an amphiphilic helical structure.
Dietary fatty acids serve as objective biomarkers for the estimation of habitual diet mainly because biomarkers are free of memory bias or inaccuracies of food databases. The aim of the present work encompassed the implementation of a gas chromatographical method coupled with a mass spectrometrical and flame-ionization detector for analysis of fatty acid biomarkers in human biospecimens, their analytical determination and statistical evaluation in two different study populations and different biospecimens as well as the elaboration of adverse reactions to food ingredients with special focus on food allergies and food intolerances in the context of a possible implementation into an application for consumer health. The first aim was the identification of potential influence of fatty acid biomarkers on desaturase and elongase indexes (Δ9DI, Δ6DI, Δ5DI and ELOVLI5), which are factors in type 2 diabetes risk, in breast adipose tissue from healthy women. Influence of further variables on respective indexes was also investigated. 40 samples were investigated and potential variables were either collected by questionnaire or determined. Principle component analysis was applied for fatty acid biomarkers (PCdiet1, PCdiet2 and PCdiet3 representative for the dietary intake of vegetable oils/nuts, fish and partially hydrogenated vegetable oils), endogenous estrogens (PCE1) and oxysterols (PCOxy1). Multiple linear regression models were applied. Δ9DI and Δ6DI were influenced non-significantly and significantly negatively by PCdiet2 supporting a putative beneficial effect of vegetable oils and nuts on type 2 diabetes risk factors. ELOVLI5 and Δ5DI were influenced significantly and non-significantly positively by PCdiet1 supporting a putative beneficial effect of fish consumption on type 2 diabetes risk factors. On the other hand, PCdiet1 also significantly and non-significantly positively influenced Δ9DI and Δ6DI supporting a putative adverse effect of fish biomarkers on type 2 diabetes risk factors. The opposing influences of PCdiet1 suggesting an ambivalent role of dietary intake of fish on investigated indexes. Δ6DI was significantly positively influenced by PCdiet3 and number of pregnancies supporting a putative adverse effect of partially hydrogenated vegetable oils and pregnancies on type 2 diabetes risk factors. Lifestyle factors like smoking significantly and non-significantly influenced Δ9DI and Δ6DI putatively adversely. Δ5DI was influenced significantly positively by estrogen active drugs suggesting a putative beneficial effect on type 2 diabetes risk factors. It must be considered that a variation coefficient of up to 0.44 only explained 44% of variance of the respective indexes, suggesting other influencing factors might play a role. The second aim was the implementation of a gas chromatographical method coupled with a mass spectrometrical and flame-ionization detector for analysis of fatty acid biomarkers in human biospecimens. The method was optimized for separation and detection of 40 fatty acids. Mean recovery for tridecanoic acid was x(tridecanoic acid) = 90.51% and for nonadecanoic acid x(nonadecanoic acid) = 96.21%. Thus, there was no significant loss of fatty acids with shorter and longer carbon chains over the extraction process to be expected. Limit of detections were calculated in adipose tissue samples and ranged from 0.007 to 0.077% of the proportion of the respective fatty acid to total fatty acids. The third aim was the investigation if differentiation between breast glandular and adipose tissue had a relevant impact on the analysis of dietary fatty acid biomarkers or if contamination of breast glandular with breast adipose tissue and vice versa was neglectable for the analysis of dietary fatty acid biomarkers. No statistical significant differences were observed for all investigated fatty acid biomarkers (pentadecanoic-, heptadecanoic-, trans palmitoleic-, eicosapentaenoic-, docosahexaenoic-, linoleic and α-linolenic acid) between breast glandular and adipose tissue. Thus, differentiation between breast glandular and adipose tissue seems not to be necessary for the analysis of fatty acids serving as biomarkers for the intake of specific food groups. Potential influence of mixed breast tissue on fatty acid biomarkers analysis seems to be neglectable. The fourth aim was the determination of fatty acid biomarkers in adipose tissue in another study population from healthy participants. 27 adipose tissue samples were analyzed. Milk and ruminant fat biomarkers exhibited proportions of 0.47% for pentadecanoic acid, 0.34% for heptadecanoic acid and 0.25% for trans palmitoleic acid. Fish fatty acid biomarkers revealed proportions of 0.034% for eicosapentaenoic acid and 0.061% for docosahexaenoic acid. The mean proportion of vegetable oils and nuts biomarkers were 9.58% for linoleic acid and 0.48% for α-linolenic acid in all adipose tissues. Principle component analysis was applied for the fatty acid biomarkers to provide objective markers of habitual diet for this study population. PCdiet1 was mainly characterized by pentadecanoic acid, heptadecanoic acid and trans palmitoleic acid and therefore served as a principle component for the dietary intake of milk and ruminant fat. PCdiet2 and PCdiet3 only exhibited pattern for ω3 and ω6 fatty acids but not for dietary intake of specific food groups and could therefore not used as objective marker. PCdiet1, 2 and 3 explained 82.76% of variance. The last aim of this thesis was the elaboration of adverse reactions to food ingredients with special focus on food allergies and food intolerances in the context of a possible implementation into an application for consumer health. Scientific information on adverse reactions to food ingredients and trigger substances was provided in this thesis and possible implementation strategies were evaluated. For food allergens, which have regulatory requirements in the context of labelling, a strategy was elaborated, where it is necessary to provide information on the list of ingredients, the nexus ’contain’ and the respective food allergen as well as information on the name of the product. For food intolerances, which do not have regulatory requirements, limits were shown in the context of the application. If the elaborated food intolerances shall be implemented into the application, a professional dietary concept has to be developed for every food intolerance because of the complexity of the implementation.
As part of the parasympathetic nervous system, muscarinic receptors are involved in the regulation of numerous functions in the human body. However, targeting a specific subtype of muscarinic receptors is challenging due to the high degree of similarity within the binding site of the endogenous neurotransmitter acetylcholine. Therefore, this study focused on the investigation of dualsteric ligands. Such hybrid ligands target the orthosteric acetylcholine binding site and, simultaneously, a distinct allosteric binding site. Since allosteric binding regions show significant structural differences throughout muscarinic receptor subtypes, it was aimed to produce selective ligands by means of combination of two pharmacophores in one molecule. Herein, the thienopyridine derivatives LY2033298 and LY2119620 were chosen as allosteric moieties. Based on literature studies, the investigated allosteric modulators were analyzed in terms of adequate attachment points for the combination with an orthosteric agonist. As orthosteric units, muscarinic superagonist iperoxo, xanomeline, and TMA were applied in this work. Since the distance between orthosteric and allosteric moieties plays a crucial role for dualsteric ligand binding, the linker chain length was also varied. Pharmacological investigations of the synthesized hybrid ligands were perfomed via FRET- and BRET-assay measurements.